Point72 Hong Kong’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-62,178
| Closed | -$4.86M | – | 507 |
|
|
2025
Q2 | $4.86M | Buy |
+62,178
| New | +$4.64M | 0.32% | 76 |
|
|
2024
Q4 | – | Sell |
-1,005
| Closed | -$66.3K | – | 460 |
|
|
2024
Q3 | $66.3K | Buy |
+1,005
| New | +$73K | ﹤0.01% | 356 |
|
|
2022
Q4 | – | Sell |
-6,213
| Closed | -$513K | – | 606 |
|
|
2022
Q3 | $513K | Buy |
6,213
+5,887
| +1,806% | +$566K | 0.02% | 739 |
|
|
2022
Q2 | $31K | Buy |
326
+136
| +72% | +$14.1K | ﹤0.01% | 1461 |
|
|
2022
Q1 | $22K | Sell |
190
-11,955
| -98% | -$1.34M | ﹤0.01% | 1512 |
|
|
2021
Q4 | $1.57M | Buy |
+12,145
| New | +$1.42M | 0.05% | 418 |
|
|
2021
Q3 | – | Sell |
-25,706
| Closed | -$2.93M | – | 2112 |
|
|
2021
Q2 | $2.66M | Buy |
25,706
+8,432
| +49% | +$795K | 0.09% | 315 |
|
|
2021
Q1 | $1.45M | Sell |
17,274
-6,118
| -26% | -$517K | 0.05% | 524 |
|
|
2020
Q4 | $2.13M | Buy |
23,392
+20,631
| +747% | +$1.71M | 0.1% | 266 |
|
|
2020
Q3 | $220K | Buy |
+2,761
| New | +$215K | 0.02% | 429 |
|
|
2020
Q2 | – | Sell |
-69
| Closed | -$4K | – | 1224 |
|
|
2020
Q1 | $4K | Buy |
+69
| New | +$4.98K | ﹤0.01% | 797 |
|
|
2019
Q4 | – | Sell |
-1,479
| Closed | -$108K | – | 1235 |
|
|
2019
Q3 | $108K | Sell |
1,479
-15,843
| -91% | -$1.11M | 0.03% | 438 |
|
|
2019
Q2 | $1.07M | Buy |
+17,322
| New | +$1.05M | 0.29% | 33 |
|
|
2019
Q1 | – | Sell |
-672
| Closed | -$34K | – | 1098 |
|
|
2018
Q4 | $34K | Buy |
+672
| New | +$34K | 0.02% | 372 |
|
|
2018
Q1 | – | Sell |
-1,722
| Closed | -$65K | – | 971 |
|
|
2017
Q4 | $65K | Buy |
1,722
+585
| +51% | +$21.5K | 0.05% | 174 |
|
|
2017
Q3 | $41K | Buy |
1,137
+519
| +84% | +$19.8K | 0.03% | 282 |
|
|
2017
Q2 | $24K | Sell |
618
-951
| -61% | -$34.7K | 0.03% | 344 |
|
|
2017
Q1 | $49K | Buy |
+1,569
| New | +$49.1K | 0.06% | 242 |
|
|
2016
Q3 | – | Sell |
-1,200
| Closed | -$40K | – | 771 |
|
|
2016
Q2 | $40K | Buy |
1,200
+900
| +300% | +$30.8K | 0.05% | 283 |
|
|
2016
Q1 | $9K | Hold |
300
| – | – | 0.02% | 378 |
|
|
2015
Q4 | $8K | Sell |
300
-1,860
| -86% | -$48.3K | 0.03% | 299 |
|
|
2015
Q3 | $51K | Buy |
+2,160
| New | +$52.1K | 0.08% | 78 |
|
|
2015
Q2 | – | Sell |
-2,160
| Closed | -$51K | – | 202 |
|
|
2015
Q1 | $51K | Sell |
2,160
-5,700
| -73% | -$128K | 0.05% | 197 |
|
|
2014
Q4 | $167K | Buy |
+7,860
| New | +$158K | 0.16% | 207 |
|
Other funds holding EW
Point72 Hong Kong's EW Position: Q3 2025 in Review
Point72 Hong Kong sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 62,178 shares — an estimated $4.86M sold.
Point72 Hong Kong first reported a position in EW in Q4 2014 and held it in 24 quarters. The position peaked at $4.86M in Q2 2025. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.
- Point72 Hong Kong reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
- Point72 Hong Kong sold 62,178 Edwards Lifesciences shares in Q3 2025, an estimated $4.86M.
- Point72 Hong Kong first reported a position in Edwards Lifesciences in Q4 2014 and held it in 24 quarters.
- Point72 Hong Kong's Edwards Lifesciences position peaked at $4.86M in Q2 2025.
- 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.
Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.